• Mon - Sat 8:00 - 6:30, Sunday - CLOSED

Generics on the way? Top drugs in danger of losing patent protection – Endpoints News

Generics on the way? Top drugs in danger of losing patent protection – Endpoints News

February 9, 2022 01:58 PM ESTUpdated 02:10 PMPharma

Generics on the way? Top drugs in danger of losing patent protection

Paul Schloesser

Associate Editor

Generic drug entry tends to signal the end of an era — patents expire, competitors reach settlements and prices are cut.

The storyline tends to play out in mostly the same way: patents and exclusivity protections eventually expire, competition swoops in, and within a few months, they’ve transformed the market into a new, less expensive and less marketed landscape.

At least that’s the theory. The reality isn’t always that simple.

Keep reading Endpoints with a free subscription

Unlock this story instantly and join 133,000+ biopharma pros reading Endpoints daily — and it's free.